Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

BYR

Bayer Ord (BYR)

Bayer Ord
De:
Trier par:
 Showing the most relevant articles for your search:LSE:BYR
DateHeureSourceTitreSymboleSociété
14/05/202411h15Alliance NewsAlliance NewsTOP NEWS: Bayer performs "as expected" with quarterly sales declineLSE:BYRBayer Ord
05/03/202413h17Alliance NewsAlliance NewsUPDATE: Bayer denies split-up as "not now" while swings to annual lossLSE:BYRBayer Ord
05/03/202411h13Alliance NewsAlliance NewsTOP NEWS: Bayer swings to annual loss on falling sales as costs riseLSE:BYRBayer Ord
04/03/202410h35Alliance NewsAlliance NewsBayer acquires European marketing rights to acoramidis heart treatmentLSE:BYRBayer Ord
19/02/202419h17Alliance NewsAlliance NewsTOP NEWS: Bayer slashes dividend in commitment to cutting down debtLSE:BYRBayer Ord
13/02/202418h07Alliance NewsAlliance NewsIN BRIEF: Bayer notes first patient in GenePHIT trialLSE:BYRBayer Ord
18/01/202407h09Alliance NewsAlliance NewsChemical firm Bayer confirms 'significant' workforce cuts in GermanyLSE:BYRBayer Ord
11/01/202415h29Alliance NewsAlliance NewsCORRECT: RTW Biotech's manager invests USD127 million in Ji XingLSE:BYRBayer Ord
08/01/202419h12Alliance NewsAlliance NewsBayer reports progress on two fronts for menopausal drug, elinzanetantLSE:BYRBayer Ord
08/01/202413h27Alliance NewsAlliance NewsRTW Biotech Opportunities invests USD127 million in investee Ji XingLSE:BYRBayer Ord
19/12/202306h52Alliance NewsAlliance NewsBayer's Monsanto to pay USD857 million over chemicals in schoolLSE:BYRBayer Ord
20/11/202311h51Alliance NewsAlliance NewsTOP NEWS: Bayer stock plunges on study blow for blood thinnerLSE:BYRBayer Ord
08/11/202309h40Alliance NewsAlliance NewsTOP NEWS: Bayer considers splitting up as quarterly loss balloonsLSE:BYRBayer Ord
01/11/202313h41Alliance NewsAlliance NewsBayer loses third consecutive US damages trial over Roundup weedkillerLSE:BYRBayer Ord
08/08/202309h03Alliance NewsAlliance NewsTOP NEWS: Bayer loss widens to nearly EUR2 billion on glyphosate hitLSE:BYRBayer Ord
24/07/202321h26Alliance NewsAlliance NewsTOP NEWS: Bayer cuts guidance on lower prices of glyphosate productsLSE:BYRBayer Ord
05/06/202312h39Alliance NewsAlliance NewsIN BRIEF: Bayer partners with Acquitas on lipid nanoparticle techLSE:BYRBayer Ord
11/05/202313h21Alliance NewsAlliance NewsTOP NEWS: Bayer shares fall as sales suffer on lower pricingLSE:BYRBayer Ord
28/02/202312h09Alliance NewsAlliance NewsBayer sees strong performance over 2022 but cautious over inflationLSE:BYRBayer Ord
10/02/202311h54Alliance NewsAlliance NewsIN BRIEF: Bayer's Kerendia granted label update by European CommissionLSE:BYRBayer Ord
08/02/202320h13Alliance NewsAlliance NewsTOP NEWS: Bayer appoints Bill Anderson as new chief executiveLSE:BYRBayer Ord
23/01/202312h02Alliance NewsAlliance NewsBayer's Ultravist wins contrast-enhanced mammography approval in EULSE:BYRBayer Ord
10/11/202212h10Alliance NewsAlliance NewsBayer buys German biotechnology start-up TargenomixLSE:BYRBayer Ord
09/09/202207h40Alliance NewsAlliance NewsRegeneron shares surge on positive Eylea trial dataLSE:BYRBayer Ord
12/08/202213h02Alliance NewsAlliance NewsTribunal rules against BASF in seed businesses dispute with BayerLSE:BYRBayer Ord
04/08/202209h48Alliance NewsAlliance NewsTOP NEWS: Legal woes hit Bayer's profit in second quarterLSE:BYRBayer Ord
21/06/202222h53Alliance NewsAlliance NewsUS high court denies Bayer bid to block Roundup weedkiller lawsuitsLSE:BYRBayer Ord
10/05/202209h00Alliance NewsAlliance NewsTOP NEWS: Bayer makes good start to 2022 with strong quarterly salesLSE:BYRBayer Ord
22/04/202213h16Alliance NewsAlliance NewsIN BRIEF: Bayer seeks further approval for darolutamide in ChinaLSE:BYRBayer Ord
04/04/202220h09Alliance NewsAlliance NewsIN BRIEF: Bayer notes positive new data for finerenoneLSE:BYRBayer Ord
 Showing the most relevant articles for your search:LSE:BYR